Cibc Asset Management Inc Glaukos Corp Transaction History

Cibc Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$34.86 - $63.77 $134,489 - $246,024	-3,858 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$44.33 - $57.82 $171,025 - $223,069	3,858 New	3,858 $223,000
Q3 2021 Nov 09, 2021	SELL	$47.43 - $84.23 $139,539 - $247,804	-2,942 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$70.43 - $97.42 $1,126 - $1,558	-16 Reduced 0.54%	2,942 $247,000
Q4 2020 Feb 03, 2021	BUY	$48.9 - $75.26 $144,646 - $222,619	2,958 New	2,958 $223,000

340

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.85B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cibc Asset Management Inc with notifications on news.